SCHEMBL23357115

SCHEMBL23357115

CNC(=O)c1ccc(CC(CN2C(=O)c3ccccc3C2=O)NC(=O)O)cc1F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ OPRD1 P41143 3/20 0.44
▸ ALDH1A1 P00352 3/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ ROCK2 O75116 1/20 0.40
▸ RPS6KA5 O75582 1/20 0.40
▸ RPS6KA4 O75676 1/20 0.40
▸ PRKACA P17612 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ GSK3B P49841 1/20 0.40
▸ PRKX P51817 1/20 0.40
▸ LIMK1 P53667 1/20 0.40
▸ ROCK1 Q13464 1/20 0.40
▸ PRKG1 Q13976 1/20 0.40
▸ CLK4 Q9HAZ1 1/20 0.40
▸ HDAC1 Q13547 4/20 0.40
▸ HDAC4 P56524 4/20 0.40
▸ HDAC6 Q9UBN7 4/20 0.40
▸ HDAC7 Q8WUI4 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23357112 1.00 OPRD1 (0.44) OPRD1ALDH1A1RAB9AKDM4EHPGD
SCHEMBL27086846 0.88 HDAC1 (0.39) ALDH1A1RAB9AKDM4EHPGDROCK2
SCHEMBL27086840 0.88 HDAC1 (0.39) ALDH1A1RAB9AKDM4EHPGDROCK2
SCHEMBL29688159 0.87 OPRD1 (0.41) OPRD1ALDH1A1RAB9AKDM4EHPGD
SCHEMBL23375885 0.87 OPRD1 (0.41) OPRD1ALDH1A1RAB9AKDM4EHPGD
SCHEMBL23375855 0.84 ALDH1A1 (0.45) OPRD1ALDH1A1RAB9AKDM4EHPGD
Hydrochloric Acid SCHEMBL23357206 0.83 ALDH1A1 (0.44) OPRD1ALDH1A1RAB9AKDM4EHPGD
Hydrochloric Acid SCHEMBL23357208 0.83 ALDH1A1 (0.44) OPRD1ALDH1A1RAB9AKDM4EHPGD
SCHEMBL23357314 0.82 OPRD1 (0.55) OPRD1ALDH1A1RAB9AKDM4EHPGD
SCHEMBL23357316 0.82 OPRD1 (0.55) OPRD1ALDH1A1RAB9AKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11352316-B2 Opioid receptor modulators and products and methods related thereto EPIODYNE, INC. (US) 2022-06-07 — — US disclosed
US-20210163402-A1 OPIOID RECEPTOR MODULATORS AND PRODUCTS AND METHODS RELATED THERETO EPIODYNE, INC. 2021-06-03 — — US disclosed
US-20210147343-A1 OPIOID RECEPTOR MODULATORS AND PRODUCTS AND METHODS RELATED THERETO EPIODYNE, INC. 2021-05-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11352316-B2 Opioid receptor modulators and products and methods related thereto OPRM1, OPRD1, OPRK1 OPRD1 2/4885ALDH1A1 1571/4885RAB9A 964/4885
US-20210163402-A1 OPIOID RECEPTOR MODULATORS AND PRODUCTS AND METHODS RELATED THERETO OPRM1, OPRD1, OPRK1 OPRD1 2/4885ALDH1A1 1571/4885RAB9A 964/4885
US-20210147343-A1 OPIOID RECEPTOR MODULATORS AND PRODUCTS AND METHODS RELATED THERETO OPRM1, OPRD1, OPRK1 OPRD1 2/4885ALDH1A1 1936/4885RAB9A 947/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback